Aggregated real-time headlines, trending Google search queries, and verified dispatches in one single page.
<a href="https://news.google.com/rss/articles/CBMikgFBVV95cUxNbmtiVHZocGdMWGo0TXZVUEEwNFNpQWw0NzdiWXpvLVpmbzJ2SHNMU0gwQkNTZ05KdDZKekZGdkRic2NYU1RYQTN6MUUtTFVWQ3B6ZEpOT2VqeFFBOElUZHltdTlkSkY5UC1OMGNCcER5MDJjWlFDTEg5dEtYVGx1djdhelJVUlVvZVlHdG01Z2FnUQ?oc=5" target="_blank">Immune cell engagers in lung cancer</a>&nbsp;&nbsp;<font color="#6f6f6f">Frontiers</font>
GameStop Stock Hits a New 52-Week High: What's Going On?
The Myth of St. Francis
Nicolò Tresoldi, chi è l'attaccante del Bruges che spaventa l'Inter in Champions League
The Ballon d’Or doesn’t capture football’s wonder – Michael Olise is proof | Zito Madu
Updated every 3 minutes via FreeNewsApi, GNews, Currents API & Google News
<a href="https://news.google.com/rss/articles/CBMihAFBVV95cUxPUThfNEdKcWVJalZCY3otaS0yV2VKY09qZXRGV0lGaWNnR2ZIRkxFU1pNQmNCajV6R1l5RV9TeUo0V1NpclJtUThEWlRnNUtvRW1HblBpNmhRYnRIdjZqRjlTR3JibFlnRkRZb0ZLeDdLOS1GbDRvS0tid28tdW4ydmMxaWo?oc=5" target="_blank">New T-cell engager shows promise for advanced solid tumors</a>&nbsp;&nbsp;<font color="#6f6f6f">Medical Xpress</font>
<a href="https://news.google.com/rss/articles/CBMikgFBVV95cUxOUmt4TjI4cGt1MFVDd0hCWmxHOUZfaDJnRkVWMWFTOGFfZGpsRDhqZ1pVOFlKOFMtSjYzb1dFLXljdnc2OTdiVG5rR0paV3E2OGczLU1rYXFFcmN4cVNrRVJkcEFLNXAxdWxlaVc4YWQycXdPc0xkSXMxeW1od2lUOTdyOTQ0dWdlT1VkZ2ktSlk4Zw?oc=5" target="_blank">Cytospire hauls in $83M for a new type of T cell engager</a>&nbsp;&nbsp;<font color="#6f6f6f">BioPharma Dive</font>
<a href="https://news.google.com/rss/articles/CBMizgFBVV95cUxNeWVuZnFJanJFYWZkZ2ZIVDRsRUg1SjBoLWFpMnk4UnRkMFN0NXZGaVh5aVVOS2MwcHpYMjNXT0NmSllsWVplbW5nMUh2QjExS0QtQURqbDlXblhPazdfMzl1RU5GOElhbnpGLUwyUUxUZWZvUEphd1pRZzk1dXotTmd3MHpNc1VDVmlvbS1aNVF3MFZjU0Q0VXpSVTMtSkZuQnFLSTcyZDZRSmU4TzFHTWhXeTB6S3RPVjRPaVJoY05wdEFfY0hlNEhBYUpKUQ?oc=5" target="_blank">New bispecific T cell engager platform targets ovarian cancer in preclinical studies</a>&nbsp;&nbsp;<font color="#6f6f6f">Drug Target Review</font>
<a href="https://news.google.com/rss/articles/CBMiiAFBVV95cUxPQXA5TVg1cFRDRXMwdzIyUFZYWUEwRFpNUlRuUUF1Yy1zNklyQXNyNlB1cHU1UEFGS3pIZHNtaDdvaHFoYWduX2ZDdXNwTFdITzdrMWFBYWFRUHNmZ3BXVllCWFAzY0JUQjBZWlRrTDdLbnUwSGlNeGhTdHF2YUFRMldGWHFNSGNh?oc=5" target="_blank">UK's Cytospire draws in $83m for new T-cell engager platform</a>&nbsp;&nbsp;<font color="#6f6f6f">pharmaphorum</font>
<a href="https://news.google.com/rss/articles/CBMi1AJBVV95cUxNdmVzR1EwVGtCczRlaXBIc3ltVnhHX3ZsNUhlR0Rra084aXZGS2kwaTNrWlEzMHhTVXJZYVpmR2NGR1JWZjJtVE94YWJ6SV9TUV9faDMxNk9BbHhIcjFEbUkycVFDdHlHOG5XQm4wdE5sb2pEbllqUkVKaUQ3OUR3TnBmUEc5WkNNY2Fid0t2SlBQbS14ZXB6QkthSEZHZG5qS0dmREZ5Sy1YT3ROMnA3d29adkpGX2pHNkZxd2VWdUNubElHWVF1VlZsTlcxYXVXRjFjZFJlVGxiS1RGLS1URDBnbVF5VjB2YkFTZEltM3pXSEoteDY3RzVuM1VJaXpQWnNBaDBVVG5ibnZMY2NNOTJiajh5MHZVMXRUS3c1QWEyX1BVSWYyckg0M1RpTEFMZHhJbnJvZWtxbU1BaW41SGVaeFlUeXJtNVZUYUxFRDZTRE9J?oc=5" target="_blank">New-Onset Sarcoidosis During B-cell Maturation Antigen (BCMA)-Directed T-cell Engager Therapy With Teclistamab in Relapsed/Refractory High-Risk Multiple Myeloma: A Case Report and Mechanistic Insight</a>&nbsp;&nbsp;<font color="#6f6f6f">Cureus</font>
<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE55VVBjV2dfT1ZUbjBaTXpBQjFXZWhnRlJjNzdCR2hLR2owMGJ3cHZHVkdfMGQ1OWhlcXN4SE5FZ2J2SzQ1eXZXVUxnazkyaUIzX3ZZbmpVWXpaNEQzLURR?oc=5" target="_blank">New immune cell engagers for cancer immunotherapy</a>&nbsp;&nbsp;<font color="#6f6f6f">Nature</font>
<a href="https://news.google.com/rss/articles/CBMisAFBVV95cUxOczltSmhCenpHRWkwVTlPWTBCdkJHenVId3R5a0hweTQybWNfeWJjb1J4cDhSZHhKUnl1clAyanNGWXlvM1RXNl9YeG8tSVhodXVrSVBTNlc0cHhvWWRsNU1MM2FOUDQ3S0I3cUcwZjluUEQ4SHRHSVlVV1daTlF1enAySWNjZ2llQlhLTF9GN1YtRU1QbG5vN1l3WUNOb3l2LWQtSGdCMEViY3FpV1EzMA?oc=5" target="_blank">Jazz strikes new chord with AbCellera in T cell engager pact that could top $2.4B</a>&nbsp;&nbsp;<font color="#6f6f6f">BioSpace</font>
<a href="https://news.google.com/rss/articles/CBMisAFBVV95cUxOSHBRa0xBcUVuTWpJMlZjMTBFT3JUZF9PbXR3WnBWTFp6bVNZQWRqOEd6cmdNbU5HdFdFRHdIb1UxNmptQ3hQU1E2azFiRG5Mbk0xd0ZZaG9FVmJ5MnhtZllYSEVYeUFjeTVUdGtSNmNtS2NXNFRKX252TlVDWC1xcmtIeXJFcUkyTWJwdFBTV3pzMlZFRW1vdUVUZDhzQlZwTG96cTN1Z1RwODV0OENZbQ?oc=5" target="_blank">Cullinan Therapeutics Shares New Clinical Data Across Its Portfolio of T Cell Engager Programs Targeting CD19 and BCMA in Autoimmune Diseases</a>&nbsp;&nbsp;<font color="#6f6f6f">Yahoo Finance</font>
<a href="https://news.google.com/rss/articles/CBMid0FVX3lxTE9OdF92cGY3SV9sVXNpcDRPUzhlWFJ4UG1iZFpqNUJLOE9peFNTeFBMOHdfTDNWUW9tRDd6eTNHbzR0V1h2R3hrOUJQel9ndFNjYVJSMWd6U0tPZnNpNkprTzBQWWZ2dnkyWjJHYmVfRUxPYWJ1Nk9r?oc=5" target="_blank">New Strategies and Platforms for Gastroesophageal Cancer</a>&nbsp;&nbsp;<font color="#6f6f6f">MedPage Today</font>
<a href="https://news.google.com/rss/articles/CBMikgFBVV95cUxONC1tWnB6TW9ObURvWnV5TS1adHhWZmdKOFoyRjlPU2tSejFPZkVheFFnYjJxVnFVZDRSTTdEdGxWQUY4T2UwUHZTVWYxX3hEcGVBeTA0dFJfdC1BM1BlVzM2UG1fY1ZtX01rYXBvYjdueFFRTVkzMXBzdlMzdzg0cFZ1Y1B0M0tfX29uVXltM0VLUQ?oc=5" target="_blank">Revolutionizing cancer immunotherapy: T cell engagers beyond hematologic malignancies toward solid tumors</a>&nbsp;&nbsp;<font color="#6f6f6f">Frontiers</font>
<a href="https://news.google.com/rss/articles/CBMioAFBVV95cUxOR3lvTHNKd01HTEExTmZrQWpMSU1CbFpJX0RJcVlqZms3RFpvMWNMUTVRb2d2Q18taXNVbk5rOUpMYjVvX2pMRlZUb2tKbVZlVzlFSDBKNnBDU0lwZERKSWMxYUZfV2pXSHptUU5aOE83VEk0cWdJcDVmQ2liR1VhZlhVY3djQVc2MUFYUEZvNEdaZlNXYkRzTFlnS0E3dzhU?oc=5" target="_blank">New Experimental Drug Shrinks Tumors in Prostate Cancer Clinical Trial</a>&nbsp;&nbsp;<font color="#6f6f6f">ScienceAlert</font>
<a href="https://news.google.com/rss/articles/CBMixwFBVV95cUxPdUkzTk05WHhDbjZvRzhXWmJmVlNyZTB0aFh3V1dOZGVVOHlPaTUwME53LU5fOWVydmtldU5PVWFQZTFWTENpdmpVUDh6TTJmM0tsV0JuUW5CSGpFYkpUNVpXYW95Q21jSEhYYl9ndmlMU3dlakRnMGtRTlg3Z0xtMXljd3d3bWJEYXl5c2RTSHZxcGY1RFRXVGJ4RmZEaVV2YXZKNlppdmxpVmxQNmpUWTZzT0RVT3EyZzhDVVRqV1FoU3Fucmxv?oc=5" target="_blank">Wistar scientists develop new bispecific T cell engager to target ovarian cancer</a>&nbsp;&nbsp;<font color="#6f6f6f">News-Medical</font>
<a href="https://news.google.com/rss/articles/CBMiqwFBVV95cUxNQ2hDWnkybkVwbVFDbUhQMzU3YW9WSmpCdkMwN3VPeDNVOHQwTVZDVm1OcTBBN3JYdXBLeE93RFgyenJPa1JFM1pONlgzV2RpeTNnOFYwS25wbGRyWVp5VEh5Uk04RUphUWtYVmJ1OVBZUEh5Wm9HaFZoakstUlZHNlphSzh2SW9URjdMSEMzWUpyLURvZFlfWFltTzczcVRRODJ6TlctakFkeE0?oc=5" target="_blank">Gilead's $2.2B Ouro buyout delivers autoimmune T-cell engager, new purpose for Galapagos</a>&nbsp;&nbsp;<font color="#6f6f6f">Fierce Biotech</font>
<a href="https://news.google.com/rss/articles/CBMinAFBVV95cUxOYkRNZE11NGFRcVFUVWRWcGx6WjFYVHpwRkZiQWFyNTVrcExZMWR3OVEtTFdBUUxpZHEycVFCMThUbndvN2Y3RTNRZEdONHhFMmZ4ZjFNdlY0bUJyVEVGdk9feV9pM2dGWG9jeDhYVUZjOW1xNHQyelkxazNfQ2FQSVdUOHZOT2MtanJicG50WGJQQ09VSVVjYkZLLWk?oc=5" target="_blank">AbCellera, Vertex partner on next-gen T-cell engagers</a>&nbsp;&nbsp;<font color="#6f6f6f">BioPharma Dive</font>
<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE8xcjViV1Z3MGZNNDU3V1ZId2tnZ2RHZHNBZTdyOXN6UTRvVlp3RWdkalEtZkRpNGtTRmdMMVRjU3gycVFCeGRuLXVyY3RYYlRWTWhSSHQ3TkFSakZBNmRZ?oc=5" target="_blank">A modular “Catch-and-Play” platform for rapid T-cell engager target assembly for personalised cancer treatment</a>&nbsp;&nbsp;<font color="#6f6f6f">Nature</font>
<a href="https://news.google.com/rss/articles/CBMivwJBVV95cUxNM3dKR2otVnJWTkFQWlZZNWR5cUw1X3drakFPdVNENko5a3gtXzVQUkZ0Wkd4RHVfRVZLNDNVZ2x3UDFuZlVHYlhsWVdmZ21kcElGUzFBZS1KM3JBVUNJNHpGSWxNVGNWYWN1UHZuVWo4THVKWFhBbG5JNlBrVWNpbHVtVGJPWGtQRkpTQlA3anNEYzY0U0QtNWlxSEhWWFVGN1dWT1NVb05zYnpyQ3JnTWgyWWlTb0pRRE1sb2l2c2pBaGhQNjBtZW43WFFpY1lnZ0FIdDZXWlV0N0ZoTC12ZS1VbXZodGJ2N21CQUVITlZwX0NDZXd5RVRjamtsR1pQUDdFSnQwSG0wdGNVYUo0UW9Hc0t4S3hEQnRld0p0NFhPS0g0dG02Vl8wa2E4SXhTY1B3blByVENiZWVwQ29Z?oc=5" target="_blank">Calidi Biotherapeutics Presents New Data on CLD-501, Its In</a>&nbsp;&nbsp;<font color="#6f6f6f">GlobeNewswire</font>
<a href="https://news.google.com/rss/articles/CBMikgFBVV95cUxNbUpxNTFqRDRfZ1ZSWkxaNElFaDE4T2FvTVRZNDcxX0tXc2xoZW11LXpZVU1nbWx6QXUybUVXTDVWZ21ubkkyUjVxSy1zWEdpWG1sR2FRTTZwT1hDb0xhWHhSdy1faGZWRFV4UWp4U2RMNldKWU5ORDNRSExfeTZZTVJGaTF6NXVNWHIwR0o5aDFiQQ?oc=5" target="_blank">CAR-T and BiTE: new horizons in the treatment of rheumatic autoimmune diseases</a>&nbsp;&nbsp;<font color="#6f6f6f">Frontiers</font>
<a href="https://news.google.com/rss/articles/CBMiwgFBVV95cUxNLXBISE5GSFVSU0J3LXdlTUpVcmZsb1gtcU1MRFlCSW81UUVRNUMtaWVqVV9ESTJuYXJGYXg4SjZDY0Fsa01waU53bUZkYUJsZUJ5eVFZc3I3bVRQejBJQXIxaVRZWFMyVmx2ZHRyZy1HQnJqa1dVeW1HSzFkV3NzN2ZkeXkyWGZ6WnJtUElyWnRQUm1tS1Zpb1Ryc3dnRnN1NGJNRmdINU1WTnJpcjRQUkk0U1FWMFRYcmR2bkhIMnVnUQ?oc=5" target="_blank">Scientists explore new frontier in autoimmune disease treatment by resetting 'rogue' cells</a>&nbsp;&nbsp;<font color="#6f6f6f">PBS</font>
<a href="https://news.google.com/rss/articles/CBMiVEFVX3lxTE0zWm0tRmhjUzhjekpSOGYwUi1iMGRTRGhkNTBELVNSS0NxcXZhQXRPdnVfWkxhZ1dqbFExR1BNVVl1Vy1TY0pwU3JKZ0o1R2w1clhGaQ?oc=5" target="_blank">New T-cell engager shows promise against treatment-resistant prostate cancer</a>&nbsp;&nbsp;<font color="#6f6f6f">DongA Science</font>
<a href="https://news.google.com/rss/articles/CBMiqgFBVV95cUxQbmFKbGRKaG5UbXJ0eTBRZE93aUItUFJZNXJSNGZQUXFtZThEM3R4NHRZQTVWZUxrbzY5ZGU0OWRzY0JhUnEwcE5QLUlWX0lkQzdKSDRxdUJvSU1YRHNUS3F4UDNPWHVxU0lQUnZha09Ud1pCVnVyMUliLUZzUVlKNnFKSXMwNTl4Q20yOWdQdkpQSGJ0ZG8xV2ZqXzUxQXplUDRNZ3JtVWZFUQ?oc=5" target="_blank">BMS Tries Again With T Cell Engagers, Turning to Janux to Develop New Tumor-Activated Therapy</a>&nbsp;&nbsp;<font color="#6f6f6f">MedCity News</font>
<a href="https://news.google.com/rss/articles/CBMickFVX3lxTFBVaUJ4Q0pZRDdNNXJ4TEkxU0c5YjZldGF0S0ZuQUhFazJ2QVlvLXp1d3ZmaGllZ3k3VVk1UTBYblRPSmx2U3NzcHduYU9TODFIS0RTRExlRVZTZk0yYXAtVnBYY0N1dy1ZOFd1dTJXM214QQ?oc=5" target="_blank">A bold new approach to autoimmune diseases</a>&nbsp;&nbsp;<font color="#6f6f6f">Johns Hopkins University</font>
<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFB3elpGQWdiX0IzakRoRm1aT2Y3dEdfSmljWk4yaDM5blZxcHpHZFc4MVVKNm93WnpWTFViaUh0SUhfeDFIakZVWWY1M2wyXzY4YVlaTnVmRko4ay1Ka0xv?oc=5" target="_blank">Bridging the gap with multispecific immune cell engagers in cancer and infectious diseases</a>&nbsp;&nbsp;<font color="#6f6f6f">Nature</font>
<a href="https://news.google.com/rss/articles/CBMimwFBVV95cUxQYklmVDFUWlh3dUdkdGlYSHRNQzlhck1IMGJZcVg5eFlxdUFaWjJhWXlEc2JBYno3NTZPcmVqY0RwOWh4eWNickZVbXZnVmswTkd5ZnRMMmo3VXN3RzAxQlhQVG91bWJIMms2eF9uRnlscnUzZUJDbmZYNWY0bFNQcWYzRnFtYVcxWHNmT1hzM0h5d0RabmNpazhINA?oc=5" target="_blank">New year sees Abbvie, Zelgen in $1.1B T-cell engager deal</a>&nbsp;&nbsp;<font color="#6f6f6f">BioWorld News</font>
<a href="https://news.google.com/rss/articles/CBMi1gFBVV95cUxNQXllX243eVpUUGJfRmhHelowLU9WOTNzZndEcDdObWhzQVI5MDdscXBrZGJza2llWlJkX1RReXZmZDB2Y3V1UzBaYjVjZTM3LTZrRjFhYWFBN2NUWVlnemU4eE96dnV6aVRBdmVwUW5iUFktUlo0MGxHN2ZYaVIxMFdEbi1kQ2tCeUtQMDI1N00xdUlIdXFZcG1pR20tX2M5MU12UVBablR6ZnBNTzlCYUJudmdrZ2RnMkFVdkNTcW5Yc0kzVG9mQUJ4VHZHSjlLSXRNTldB?oc=5" target="_blank">Powering the Next Generation of Cancer Immunotherapy: iPSC-Derived Immune Cells Meet Immune Cell Engagers</a>&nbsp;&nbsp;<font color="#6f6f6f">Evotec</font>
<a href="https://news.google.com/rss/articles/CBMikgFBVV95cUxQOUE2YU9lS0xnQm1ULUFJNVREMWJVSjBpR1Q0NHczVHNhNEZJRXR1YWN1bDU3R2Utc194NHItVVRrb1JQWXVhaWdnVUJSRm5DSDlWTWIyWUpldVMtWmduOGZONzNOeFdXWVhieG96SHFVZjF6ZlJ4RF9xOGNveXlwRjlKd1ZrUjJ3ZGJkZVBuRFA0Zw?oc=5" target="_blank">Integrating T cell signaling and metabolism to enhance T cell engager responses in solid tumors</a>&nbsp;&nbsp;<font color="#6f6f6f">Frontiers</font>
<a href="https://news.google.com/rss/articles/CBMif0FVX3lxTE1VSFhoWkp3VFFiUlZkaFNuVGM1RnVCdzlhWGxpMEk3M1dMVU9sems0dlJpdDlHWWIycDBLN2Z4c1VSc3pNOXB3a1JMWVI0Z0tNOWRDNjlNMFR0Y18yYWR5a0J5dHM4N2M3eTlKeWp5SDhKcmFqcXVKT2JIVVp1VHM?oc=5" target="_blank">A New Era for T-Cell–Engaging Therapy in Melanoma</a>&nbsp;&nbsp;<font color="#6f6f6f">ASCO Daily News</font>
<a href="https://news.google.com/rss/articles/CBMingFBVV95cUxQWEUxazB5eDlLZHRwT2RYdlE1OGU4ZDFxZ0xRZnlhX0pnSmVNbE5zbHkzUWRWdDA5cGFzWXRWWlBFc0hqR1o0WXFaUTdQU3BwMW1mY0UwVThmT2pNOFFtWWFuTnBxTWxuMlAyVTd4VUJNT09xbjZrTjdUaXJvUzlYYXFHS2FiaTJBbzJvMkRMOXU3TVpBTE8zMWFOb0NsUQ?oc=5" target="_blank">Exploring T-Cell Engager Use in Chemotherapy-Resistant ES-SCLC</a>&nbsp;&nbsp;<font color="#6f6f6f">CancerNetwork</font>
<a href="https://news.google.com/rss/articles/CBMi4gFBVV95cUxQQ3R3UlhiRXhJR1pYc09ZREpTZlF5WnFDUnhpeGZBeVNQZnJfSnJKZmRBenp1UENUMDFNS0VlaUd4dHBlZ2J2eVZEQ01raGNseHU0NHBEbDN1cHVHWlpyMFNSVG5UN0E3SWg3UFVBbnU4UkczaDFDVy1FcmRSaEt1aUgzcjkyVGk3NW1EYWZoakxSUTdCY1lHX29lbE5KNEduLTBFdU00TVRnZTE3ajNjbHhGNjNkXzhDeTF6djU5dV9HWm5ja3ROQXFrS05WVmxKMGt6d0R5Q21VcjAxQXNNbDJ3?oc=5" target="_blank">New Approach to Adoptive T-Cell Therapy Shows Promise for Boosting Immune Response in Ovarian Cancer</a>&nbsp;&nbsp;<font color="#6f6f6f">Roswell Park Comprehensive Cancer Center</font>
<a href="https://news.google.com/rss/articles/CBMingFBVV95cUxQWXVGRXNpN0x4dEZSSkJUeUZ5cEhBSEsyRHdUTktlWGpSUFNRQVE4V25tckprbEVaR2xmM2drWDBIbDN0SFpxZjZKTWRYWThDdE5hWHlfbmxkNEpEeHlJbzNNZjVfXzZtTmJXRFVkR2gzNDQyX3R2UUpIR1VocUh2bDlLZ2xjWlhUSGdDcWY0MHNyV2JpMURTOEh4ck1TZw?oc=5" target="_blank">How New Therapies Are Changing the Game for Small Cell Lung Cancer</a>&nbsp;&nbsp;<font color="#6f6f6f">Cure Today</font>